Pathologic Staging (pTNM)

CAP Approved Genitourinary • Ureter, Renal Pelvis 2.0.0.0 (AJCC 8th ed.)

TNM Descriptors (required only if applicable) (select all that apply)

___ m (multiple primary tumors)

___ r (recurrent)

___ y (posttreatment)

Primary Tumor (pT)

___ pTX:        Primary tumor cannot be assessed

___ pT0:        No evidence of primary tumor

___ pTa:        Papillary noninvasive carcinoma

___ pTis:        Carcinoma in situ

___ pT1:        Tumor invades subepithelial connective tissue

___ pT2:        Tumor invades the muscularis

___ pT3:        For renal pelvis only: Tumor invades beyond muscularis into peripelvic fat or into the renal parenchyma

For ureter only: Tumor invades beyond muscularis into periureteric fat

___ pT4:        Tumor invades adjacent organs, or through the kidney into the perinephric fat

Regional Lymph Nodes (pN)

___ pNX:        Regional lymph node cannot be assessed

___ pN0:        No regional lymph node metastasis

___ pN1:        Metastasis ≤2 cm in greatest dimension, in a single lymph node

___ pN2:        Metastasis >2 cm, in a single lymph node; or multiple lymph nodes

Distant Metastasis (pM)

___ Not applicable

___ pM1: Distant metastasis (specify site(s) if known)

Ureter and Renal Pelvis CAP 2.0.0.0 summary of pTNM changes AJCC 7th to 8th edition

• added “Noninvasive low-grade” to margin section
• T3 same, just split Renal Pelvis T3 from Ureter T3 for formatting
• No more N3
• N2 now includes previous N3 (N2 no longer has upper limit of 5 cm)

Genitourinary

Comments

Click here to leave feedback